Continuous manufacturing makes monoclonal antibody production faster, cheaper, and greener, say researchers, who predict that industry adoption of the approach will accelerate in response to ...

Fed-batch and batch bioprocessing still dominate monoclonal antibody (mAb) production, but that must change if mAbs are to become economically viable therapeutic options. Current production techniques ...

The pharmaceutical industry has been slow to adopt a business practice that is faster, safer, and more efficient than its current way of operating; that the FDA has been encouraging the industry to ...

Continued process verification (CPV) is the third stage of the product lifecycle of any medicine either within the small or large molecule arena. The CPV is the subsequent step to process design ...

The manufacture of medicines must draw on expertise from a wide range of disciplines, from the initial investigation and design of a new drug or therapeutic to wide-scale production and distribution, ...

Batch processing operations are ideal for large scale manufacturing of products that are assembled and modified in a series of stages or steps. When connected to a batch management software system, ...

DFE Pharma launches continuous manufacturing platform to accelerate and enable formulation development: Goch, Germany Wednesday, February 18, 2026, 12:00 Hrs [IST] DFE Pharma, a g ...

“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...

You don’t have to go it alone when searching for and maintaining the perfect batch. Through machine learning and AI-based batch control, the arduous search becomes easier to realize.

The global Process Analytical Technology (PAT) market is experiencing rapid expansion, driven by the pharmaceutical ...